Medable Sustainability Profile
Medable, officially known as Medable Inc., is a pioneering force in the digital health industry, headquartered in the United States. Founded in 2015, the company has rapidly established itself as a leader in decentralised clinical trials, transforming the way clinical research is conducted. With a focus on patient-centric solutions, Medable offers a comprehensive platform that streamlines trial processes, enhances patient engagement, and accelerates drug development. The company operates primarily in North America and Europe, providing innovative services that include remote patient monitoring, data collection, and trial management. Medable's unique approach leverages advanced technology to improve accessibility and efficiency in clinical trials, positioning it as a key player in the evolving landscape of healthcare. Notable achievements include partnerships with major pharmaceutical companies and recognition for its contributions to advancing clinical research methodologies.
DitchCarbon Score
How does Medable's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medable's score of 27 is lower than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Medable's reported carbon emissions
Medable, headquartered in the United States, has not reported any carbon emissions data for the most recent year. However, the company has made significant climate commitments through the Science Based Targets initiative (SBTi). Medable has set an ambitious target to maintain zero Scope 1 and Scope 2 emissions through 2030, using 2021 as the base year. This commitment reflects a 100% reduction target for these scopes. Additionally, Medable aims to measure and reduce its Scope 3 emissions, although specific targets for this scope have not been detailed. These targets are aligned with the necessary reductions to limit global warming to 1.5°C, demonstrating Medable's commitment to sustainable practices within the software and services sector. The company is classified as a small or medium enterprise (SME) and is actively working towards achieving these goals as part of its broader climate strategy.
How Carbon Intensive is Medable's Industry?
How Carbon Intensive is Medable's Location?
Medable's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Medable has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Syneos Health
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.